ctrl K

Price Alert

Protagonist Therapeutics ... (PTGX)

NASDAQ: PTGX · Real-Time Price · USD

66.86

2.16 (3.34%)

At close: Sep 26, 2025, 1:12 PM

Protagonist Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	434.43M	60M	26.58M	27.36M
Cost of Revenue	n/a	n/a	1.03M	2.77M
Gross Profit	431.47M	60M	25.55M	24.58M
Operating Income	252.84M	-93.65M	-131.37M	-125.84M
Interest Income	26.32M	14.9M	4.06M	443K
Pretax Income	279.41M	-78.95M	-127.39M	-125.55M
Net Income	275.19M	-78.95M	-123.41M	-122.63M
Selling & General & Admin	43.46M	33.49M	31.74M	27.2M
Research & Development	138.13M	120.16M	126.22M	126.01M
Other Expenses	n/a	n/a	-80K	-149K
Operating Expenses	181.59M	153.65M	157.95M	153.2M
Interest Expense	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	181.59M	153.65M	157.95M	153.2M
Income Tax Expense	4.22M	n/a	-3.98M	-2.92M
Shares Outstanding (Basic)	61.57M	56.76M	49.04M	46.32M
Shares Outstanding (Diluted)	65.08M	56.76M	49.04M	46.32M
EPS (Basic)	4.47	-1.39	-2.52	-2.65
EPS (Diluted)	4.23	-1.39	-2.52	-2.65
EBITDA	252.84M	-90.34M	-131.37M	-123.07M
EBIT	252.84M	-93.65M	-131.37M	-125.84M
Depreciation & Amortization	n/a	3.31M	1.03M	2.77M

Ask AI